NHS rolls out monoclonal antibody treatment for rare bone disease

NHS rolls out monoclonal antibody treatment for rare bone disease

The NHS in the UK is introducing Crysvita for adults with X-linked hypophosphataemia, a rare bone disease. The treatment will be available in specialist centers, allowing patients to administer it at home.

Read More

Did you find this insightful?